MRI-guided radiotherapy for rectal cancer
Part of Cancer clinical trials.
This trial tests whether using MRI scans to guide radiotherapy can improve treatment for people with a certain type of rectal cancer. It focuses on patients whose tumors have not spread to other parts of the body and who have specific tumor features seen on MRI.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of adenocarcinoma (the most common type) of the rectum.
- Your tumor must be at a stage where it has not spread to distant organs (cM0).
- You must not have had radiation therapy to the pelvic area before.
- You must be 18 years or older and have a good performance status (ECOG 0 or 1, meaning you are fully active or only limited in physically strenuous activity).
- You must have adequate blood counts and liver function (as determined by your doctor).
- You must not have certain MRI findings: no involvement of the mesorectal fascia, no extramesorectal lymph nodes, and no extramural venous invasion (EMVI).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a special MRI technique to help doctors better understand rectal cancer before treatment. It is for people who will receive chemotherapy and radiation before surgery.
This trial tests a new way of delivering radiation therapy for rectal cancer before surgery. It aims to see if adapting the radiation based on how the tumor shrinks can be more effective and safer than standard treatment.
This trial tests a new way of giving radiation therapy for rectal cancer, using MRI scans to aim the radiation more precisely. It's for people who need chemotherapy and radiation before surgery, and it aims to make treatment more effective while reducing side effects.
This trial tests a new type of radiation therapy that uses real-time MRI imaging to adjust the radiation precisely to your tumor. It is designed to improve the accuracy of treatment for locally advanced rectal cancer, potentially reducing damage to nearby healthy tissue.
This Phase 1 study tests a radiation treatment approach guided by MRI scans to help keep nearby organs functioning while treating rectal cancer. It is designed to find a safe, effective way to target the tumor and adjust treatment during the course of therapy.
This trial tests a short course of radiation with chemotherapy, targeted therapy, and immunotherapy before surgery for locally advanced rectal cancer. It aims to shrink the tumor and improve outcomes.
Hear when a new Locally Advanced Rectal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.